Progress in antischistosomal N,N′-diaryl urea SAR

Jianbo Wu, Chunkai Wang, Derek Leas, Mireille Vargas, Karen L. White, David M. Shackleford, Gong Chen, Austin G. Sanford, Ryan M. Hemsley, Paul H. Davis, Yuxiang Dong, Susan A. Charman, Jennifer Keiser, Jonathan L. Vennerstrom

Research output: Contribution to journalArticleResearchpeer-review

Abstract

N,N′-Diaryl ureas have recently emerged as a new antischistosomal chemotype. We now describe physicochemical profiling, in vitro ADME, plasma exposure, and ex vivo and in vivo activities against Schistosoma mansoni for twenty new N,N′-diaryl ureas designed primarily to increase aqueous solubility, but also to maximize structural diversity. Replacement of one of the 4-fluoro-3-trifluoromethylphenyl substructures of lead N,N′-diaryl urea 1 with azaheterocycles and benzoic acids, benzamides, or benzonitriles decreased lipophilicity, and in most cases, increased aqueous solubility. There was no clear relationship between lipophilicity and metabolic stability, although all compounds with 3-trifluoromethyl-4-pyridyl substructures were metabolically stable. N,N′-diaryl ureas containing 4-fluoro-3-trifluoromethylphenyl, 3-trifluoromethyl-4-pyridyl, 2,2-difluorobenzodioxole, or 4-benzonitrile substructures had high activity against ex vivo S. mansoni and relatively low cytotoxicity. N,N-diaryl ureas with 3-trifluoromethyl-4-pyridyl and 2,2-difluorobenzodioxole substructures had the highest exposures whereas those with 4-fluoro-3-trifluoromethylphenyl substructures had the best in vivo antischistosomal activities. There was no direct correlation between compound exposure and in vivo activity.

Original languageEnglish
Pages (from-to)244-248
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume28
Issue number3
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • Antischistosomal
  • N,N′-Diaryl urea
  • SAR

Cite this

Wu, J., Wang, C., Leas, D., Vargas, M., White, K. L., Shackleford, D. M., ... Vennerstrom, J. L. (2018). Progress in antischistosomal N,N′-diaryl urea SAR. Bioorganic and Medicinal Chemistry Letters, 28(3), 244-248. https://doi.org/10.1016/j.bmcl.2017.12.064
Wu, Jianbo ; Wang, Chunkai ; Leas, Derek ; Vargas, Mireille ; White, Karen L. ; Shackleford, David M. ; Chen, Gong ; Sanford, Austin G. ; Hemsley, Ryan M. ; Davis, Paul H. ; Dong, Yuxiang ; Charman, Susan A. ; Keiser, Jennifer ; Vennerstrom, Jonathan L. / Progress in antischistosomal N,N′-diaryl urea SAR. In: Bioorganic and Medicinal Chemistry Letters. 2018 ; Vol. 28, No. 3. pp. 244-248.
@article{bac7053e486546a990cee30042919458,
title = "Progress in antischistosomal N,N′-diaryl urea SAR",
abstract = "N,N′-Diaryl ureas have recently emerged as a new antischistosomal chemotype. We now describe physicochemical profiling, in vitro ADME, plasma exposure, and ex vivo and in vivo activities against Schistosoma mansoni for twenty new N,N′-diaryl ureas designed primarily to increase aqueous solubility, but also to maximize structural diversity. Replacement of one of the 4-fluoro-3-trifluoromethylphenyl substructures of lead N,N′-diaryl urea 1 with azaheterocycles and benzoic acids, benzamides, or benzonitriles decreased lipophilicity, and in most cases, increased aqueous solubility. There was no clear relationship between lipophilicity and metabolic stability, although all compounds with 3-trifluoromethyl-4-pyridyl substructures were metabolically stable. N,N′-diaryl ureas containing 4-fluoro-3-trifluoromethylphenyl, 3-trifluoromethyl-4-pyridyl, 2,2-difluorobenzodioxole, or 4-benzonitrile substructures had high activity against ex vivo S. mansoni and relatively low cytotoxicity. N,N-diaryl ureas with 3-trifluoromethyl-4-pyridyl and 2,2-difluorobenzodioxole substructures had the highest exposures whereas those with 4-fluoro-3-trifluoromethylphenyl substructures had the best in vivo antischistosomal activities. There was no direct correlation between compound exposure and in vivo activity.",
keywords = "Antischistosomal, N,N′-Diaryl urea, SAR",
author = "Jianbo Wu and Chunkai Wang and Derek Leas and Mireille Vargas and White, {Karen L.} and Shackleford, {David M.} and Gong Chen and Sanford, {Austin G.} and Hemsley, {Ryan M.} and Davis, {Paul H.} and Yuxiang Dong and Charman, {Susan A.} and Jennifer Keiser and Vennerstrom, {Jonathan L.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.bmcl.2017.12.064",
language = "English",
volume = "28",
pages = "244--248",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Pergamon",
number = "3",

}

Wu, J, Wang, C, Leas, D, Vargas, M, White, KL, Shackleford, DM, Chen, G, Sanford, AG, Hemsley, RM, Davis, PH, Dong, Y, Charman, SA, Keiser, J & Vennerstrom, JL 2018, 'Progress in antischistosomal N,N′-diaryl urea SAR' Bioorganic and Medicinal Chemistry Letters, vol. 28, no. 3, pp. 244-248. https://doi.org/10.1016/j.bmcl.2017.12.064

Progress in antischistosomal N,N′-diaryl urea SAR. / Wu, Jianbo; Wang, Chunkai; Leas, Derek; Vargas, Mireille; White, Karen L.; Shackleford, David M.; Chen, Gong; Sanford, Austin G.; Hemsley, Ryan M.; Davis, Paul H.; Dong, Yuxiang; Charman, Susan A.; Keiser, Jennifer; Vennerstrom, Jonathan L.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 28, No. 3, 01.02.2018, p. 244-248.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Progress in antischistosomal N,N′-diaryl urea SAR

AU - Wu, Jianbo

AU - Wang, Chunkai

AU - Leas, Derek

AU - Vargas, Mireille

AU - White, Karen L.

AU - Shackleford, David M.

AU - Chen, Gong

AU - Sanford, Austin G.

AU - Hemsley, Ryan M.

AU - Davis, Paul H.

AU - Dong, Yuxiang

AU - Charman, Susan A.

AU - Keiser, Jennifer

AU - Vennerstrom, Jonathan L.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - N,N′-Diaryl ureas have recently emerged as a new antischistosomal chemotype. We now describe physicochemical profiling, in vitro ADME, plasma exposure, and ex vivo and in vivo activities against Schistosoma mansoni for twenty new N,N′-diaryl ureas designed primarily to increase aqueous solubility, but also to maximize structural diversity. Replacement of one of the 4-fluoro-3-trifluoromethylphenyl substructures of lead N,N′-diaryl urea 1 with azaheterocycles and benzoic acids, benzamides, or benzonitriles decreased lipophilicity, and in most cases, increased aqueous solubility. There was no clear relationship between lipophilicity and metabolic stability, although all compounds with 3-trifluoromethyl-4-pyridyl substructures were metabolically stable. N,N′-diaryl ureas containing 4-fluoro-3-trifluoromethylphenyl, 3-trifluoromethyl-4-pyridyl, 2,2-difluorobenzodioxole, or 4-benzonitrile substructures had high activity against ex vivo S. mansoni and relatively low cytotoxicity. N,N-diaryl ureas with 3-trifluoromethyl-4-pyridyl and 2,2-difluorobenzodioxole substructures had the highest exposures whereas those with 4-fluoro-3-trifluoromethylphenyl substructures had the best in vivo antischistosomal activities. There was no direct correlation between compound exposure and in vivo activity.

AB - N,N′-Diaryl ureas have recently emerged as a new antischistosomal chemotype. We now describe physicochemical profiling, in vitro ADME, plasma exposure, and ex vivo and in vivo activities against Schistosoma mansoni for twenty new N,N′-diaryl ureas designed primarily to increase aqueous solubility, but also to maximize structural diversity. Replacement of one of the 4-fluoro-3-trifluoromethylphenyl substructures of lead N,N′-diaryl urea 1 with azaheterocycles and benzoic acids, benzamides, or benzonitriles decreased lipophilicity, and in most cases, increased aqueous solubility. There was no clear relationship between lipophilicity and metabolic stability, although all compounds with 3-trifluoromethyl-4-pyridyl substructures were metabolically stable. N,N′-diaryl ureas containing 4-fluoro-3-trifluoromethylphenyl, 3-trifluoromethyl-4-pyridyl, 2,2-difluorobenzodioxole, or 4-benzonitrile substructures had high activity against ex vivo S. mansoni and relatively low cytotoxicity. N,N-diaryl ureas with 3-trifluoromethyl-4-pyridyl and 2,2-difluorobenzodioxole substructures had the highest exposures whereas those with 4-fluoro-3-trifluoromethylphenyl substructures had the best in vivo antischistosomal activities. There was no direct correlation between compound exposure and in vivo activity.

KW - Antischistosomal

KW - N,N′-Diaryl urea

KW - SAR

UR - http://www.scopus.com/inward/record.url?scp=85040005699&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2017.12.064

DO - 10.1016/j.bmcl.2017.12.064

M3 - Article

VL - 28

SP - 244

EP - 248

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 3

ER -